stopping glp 1 weight gain GLP-1s: Regain and Maintenance Tips GLP-1 drugs and pregnancy: Why

Tirzepatide functions as an imbalanced dual agonist, characterised by a molecular structure exhibiting a markedly higher affinity for the GIP receptor than the GLP-1 receptor

Clinical studies have shown an average weight loss of 15% to 20% over a 68-week period

Look at the quality of the ingredients, the dosage, and the company's reputation

Doctor-led medical assessment Conclusion Mounjaro is a clinically proven, dual-action management treatment that works by regulating appetite, improving insulin sensitivity, and supporting long-term metabolic health

Phentermine is a sympathomimetic amine that functions primarily as an appetite suppressant